SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-053503
Filing Date
2024-04-29
Accepted
2024-04-29 08:02:50
Documents
8
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242998-1_def14a.htm DEF 14A 840591
2 GRAPHIC bc_netincome-4c.jpg GRAPHIC 46554
3 GRAPHIC bc_tsr-4c.jpg GRAPHIC 54443
4 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 101497
5 GRAPHIC px_24carismaproxy1pg01-4c.jpg GRAPHIC 384094
6 GRAPHIC px_24carismaproxy1pg02-4c.jpg GRAPHIC 272497
7 GRAPHIC sg_sanfordzweifach-bw.jpg GRAPHIC 23287
8 GRAPHIC sg_skwet-bw.jpg GRAPHIC 28493
  Complete submission text file 0001104659-24-053503.txt   2038488
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 24886670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)